Home › Health › Clues to Why a Breakthrough Pancreatic Cancer Drug...
Health

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Key Points

Researchers are studying why patients, like former Senator Ben Sasse, eventually develop resistance to the drug daraxonrasib.

Researchers are studying why patients, like former Senator Ben Sasse, eventually develop resistance to the drug daraxonrasib.
Ben Sasse (PERSON)
Originally published by NYT Science Read original →